Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Blood and Lymph Conditions

Symptoms and General Pathology

Breast Neoplasms

Lymphedema

Breast Cancer Lymphedema

Lymphatic Diseases

Postoperative Complications

Patients will receive an intensive decongestive treatment for 5 days

Patients will receive an intensive decongestive treatment + Cellu M6 for 5 days

Patients will receive an bandages + Cellu M6 for 5 days

intensive decongestive treatment

Cellu M6

Julie MALLOIZEL-DELAUNAY, MD

This study will assess the benefit of LPG Cellu M6 in addition of intensive decongestive treatment in reducing secondary lymphoedema in breast cancer.

The main objective of the study is to assess the proportion of successfully treated patients (success rate).

That is to say patients having a reduction of excess arm volume ≥ 30% after 5 days of three types of treatment for secondary lymphoedema :

Group 1: standard intensive decongestive therapy for 5 days (bandages + manual lymphatic drainage).

Group 2: standard intensive decongestive therapy (bandages + manual lymphatic drainage) + Cellu M6 for 5 days Group 3: Bandages + Cellu M6 for 5 days

Symptomatic treatment of lymphoedema reference is intensive decongestive therapy including manual lymphatic drainage, compression of multicomponent bandaging, therapeutic exercise and skin care (HAS 2012 ISL International Society of Lymphology, 2013).

Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema

Contribution of an Endermologie LPG Cellu M6 Treatment in the Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema, During an Intensive Decongestive Treatment.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema	NCT02506530	Lymphedema	intensive decon... Cellu M6	18 Years -	University Hospital, Toulouse
Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema	NCT02506530	Lymphedema	intensive decon... Cellu M6	18 Years -	University Hospital, Toulouse

Spots Global Cancer Trial Database for intensive decongestive treatment